ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.90
-0.03 (-1.02%)
At close: Jun 05, 2025, 3:59 PM
2.90
-0.17%
After-hours: Jun 05, 2025, 07:51 PM EDT

ImmunityBio Revenue

ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending March 31, 2025, ImmunityBio generated $16.52M in revenue.
Revenue (ttm)
$14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
$21.97K
Employees
671
Market Cap
2.56B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.